'Longevity diet' puts an amino acid in the spotlight as key to healthy aging

A modified diet that takes cues from the Mediterranean model has the potential to promote healthier aging, with scientists combining a large dataset from human research with the results of an animal study to understand the mechanisms at play.

Continue Reading

Category: Aging Well, Wellness and Healthy Living, Body and Mind

Tags: University of Southern California, Longevity, Health,…

Daily weight-loss pill with low side effects advances toward US sale

A once-a-day, low-impact oral GLP-1 pill known as CX11 has passed its efficacy test on US patients to advance to the first North American Phase 3 trial. It's already cleared its first Phase 3 study in China.

Continue Reading

Category: Obesity, Illnesses and conditions, Body and Mind

Tags: GLP-1 receptor agonists, Weight Loss, clinical trials, Fat cells, peptide, Pharmaceuticals,…

GLP-1 weight-loss drugs may have an unexpected impact on crime rates

Sold under brand names like Wegovy and Ozempic, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become a popular way to curb appetite and lose weight.

Continue Reading

Category: Mental Health, Brain Health, Body and Mind

Tags: GLP-1 receptor agonists, Crime, Weight Loss, Pharmaceuticals

Brain-cell breakthrough supercharges GLP-1 weight loss and prevents plateaus

Scientists have identified a new way to supercharge the GLP-1 receptor agonist semaglutide, opening the door to boosting the drug's weight-loss power and helping long-term users push past plateaus that not even this "wonder drug" can circumvent.

Continue Reading

Category: Obesity, Illnesses and conditions, Body and Mind

Tags: National Institutes of Health (NIH), U.S. National…

Weight-loss drugs present new hope for adults with asthma

Could glucagon-like peptide-1 receptor agonists (GLP-1 RAs) nix the inflammation that drives asthma? Maybe, according to a large national study in Denmark.

Continue Reading

Category: Obesity, Illnesses and conditions, Body and Mind

Tags: GLP-1 receptor agonists, Weight Loss, Inflammation, Asthma, Asthma inhaler, Respiratory health, Lung, Chronic illness

GLP-1 drugs shown to fight arthritis independent of weight loss

A new study has shown that the popular GLP-1 weight loss drug semaglutide has the power to halt, and to some extent restore, cartilage in people suffering from osteoarthritis (OA). The finding hints at a possible use of the drug beyond weight loss.

Continue Reading

Category: Body and Mind

Tags: GLP-1 receptor agonists, Ozempic, Arthritis, Weight Loss

Page 1